Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:32 PM
Study NCT ID:
NCT04493151
Status:
COMPLETED
Last Update Posted:
2024-08-07
First Post:
2020-07-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Imipenem/Cilastatin/Relebactam PK in ECMO
Sponsor:
Joseph L. Kuti, PharmD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-27
First Submit QC Date:
None
Study First Post Date:
2020-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-02-20
Results First Submit QC Date:
None
Results First Post Date:
2024-08-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-01
Last Update Post Date:
2024-08-07
Last Update Post Date Type:
ACTUAL